1. Diagnosis, Outcome, and Management of Chylous Ascites Following Pediatric Liver Transplantation.
- Author
-
Miserachs M, Lurz E, Levman A, Ghanekar A, Cattral M, Ng V, Grant D, and Avitzur Y
- Subjects
- Adolescent, Age Factors, Ascitic Fluid chemistry, Case-Control Studies, Child, Child, Preschool, Chylous Ascites epidemiology, Chylous Ascites etiology, Chylous Ascites therapy, Diet, Fat-Restricted, Diuretics administration & dosage, Drainage methods, Female, Follow-Up Studies, Humans, Incidence, Infant, Length of Stay statistics & numerical data, Male, Octreotide administration & dosage, Postoperative Complications epidemiology, Postoperative Complications etiology, Postoperative Complications therapy, Reference Values, Retrospective Studies, Risk Factors, Severity of Illness Index, Survival Rate, Treatment Outcome, Triglycerides analysis, Chylomicrons analysis, Chylous Ascites diagnosis, End Stage Liver Disease surgery, Liver Transplantation adverse effects, Postoperative Complications diagnosis
- Abstract
Data on postoperative chylous ascites (CA) after pediatric liver transplantation (LT) are scarce. This retrospective study was conducted to identify the incidence, risk factors, management, and outcomes of postoperative CA in a large single-center pediatric LT cohort (2000-2016). The study cohort comprised 317 LTs (153 living donors and 164 deceased donors) in 310 recipients with a median age of 2.7 years. The incidence of CA was 5.4% (n = 17), diagnosed after a median time of 10 days after LT. Compared with chylomicron detection in peritoneal fluid (the gold standard), a triglyceride cutoff value of 187 mg/dL in peritoneal fluid showed insufficient sensitivity (31%) for CA diagnosis. In univariate logistic regression analyses, ascites before LT, younger age, and lower weight, height, and height-for-age z score at LT were associated with CA. Symptomatic management of CA included peritoneal drain (100%) and diuretics (76%). Therapeutic interventions included very low-fat or medium-chain triglyceride-rich diets (94%) and intravenous octreotide (6%), leading to CA resolution in all patients. CA was associated with prolonged hospital length of stay (LOS; 40 days in the CA group versus 24 days in the non-CA group; P = 0.001) but not with reduced patient or graft survival rates after a median follow-up time of 14 years. In conclusion, CA in the pediatric LT recipient is a relatively uncommon complication associated with increased hospital LOS and morbidity. Measurement of chylomicrons is recommended in patients with ascites that is more severe or persistent than expected. Dietary interventions are effective in most patients., (Copyright © 2019 by the American Association for the Study of Liver Diseases.)
- Published
- 2019
- Full Text
- View/download PDF